Virtu KCG Holdings’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-29,700
Closed -$394K 3178
2014
Q4
$394K Buy
29,700
+13,600
+84% +$174K 0.01% 1997
2014
Q3
$190K Buy
16,100
+3,800
+31% +$47.9K ﹤0.01% 2938
2014
Q2
$157K Sell
12,300
-33,800
-73% -$439K ﹤0.01% 3161
2014
Q1
$623K Sell
46,100
-51,700
-53% -$679K 0.01% 1720
2013
Q4
$1.18M Buy
97,800
+86,200
+743% +$1.02M 0.01% 1074
2013
Q3
$136K Buy
+11,600
New +$125K ﹤0.01% 3281

Other funds holding BSX

Virtu KCG Holdings's BSX Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Boston Scientific (BSX) in Q2 2017: 99,075 shares worth $2.75M. The stake represents 0.08% of the portfolio and ranks #149 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in BSX as recently as Q4 2016.

Virtu KCG Holdings first reported a position in BSX in Q3 2013 and has held it in 14 quarters since. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

  • Virtu KCG Holdings held 99,075 shares of Boston Scientific worth $2.75M as of Q2 2017.
  • Boston Scientific was a new Virtu KCG Holdings position in Q2 2017.
  • Boston Scientific made up 0.08% of Virtu KCG Holdings's portfolio in Q2 2017, its #149 holding.
  • Virtu KCG Holdings first reported a position in Boston Scientific in Q3 2013 and has held it in 14 quarters since.
  • 558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.